Also trades as: PGHH.BO (BSE) · $vol 0M
PGHH.NS NSE
Procter & Gamble Hygiene and Health Care Limited
1W: -6.4%
1M: -15.8%
3M: -25.4%
YTD: -44.6%
1Y: -49.7%
3Y: -56.0%
5Y: -45.2%
₹6,695.50 ($69.54)
+56.50 (+0.85%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$42.8B
-4.8% ▼
5Y CAGR: +3.7%
Gross Profit
$24.7B
-3.0% ▼
5Y CAGR: +2.0%
Operating Income
$11.3B
+1.3% ▲
5Y CAGR: +6.0%
Net Income
$8.6B
+0.9% ▲
5Y CAGR: +5.6%
EPS (Diluted)
$263.86
+0.9% ▲
5Y CAGR: +5.6%
EBITDA
$12.0B
-1.1% ▼
5Y CAGR: +5.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $39.0B | $39.1B | $42.1B | $45.0B | $42.8B |
| YoY Growth | +9.3% | +0.1% | +7.7% | +7.0% | -4.8% |
| Cost of Revenue | $21.8B | $16.6B | $16.3B | $19.5B | $17.6B |
| Gross Profit | $17.2B | $22.4B | $25.8B | $25.5B | $24.7B |
| Gross Margin | 44.0% | 57.4% | 61.3% | 56.6% | 57.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6.1B | $5.5B | $6.6B | $14.3B | $5.2B |
| Operating Expenses | $9.3B | $14.3B | $7.8B | $14.3B | $13.4B |
| Operating Income | $7.9B | $8.2B | $18.0B | $11.2B | $11.3B |
| Operating Margin | 20.2% | 20.9% | 42.8% | 24.9% | 26.5% |
| Interest Expense | $112M | $114M | $268M | $191M | $94M |
| Income Before Tax | $7.9B | $8.4B | $9.4B | $11.5B | $11.7B |
| Tax Expense | $2.1B | $1.6B | $2.6B | $3.0B | $3.1B |
| Net Income | $5.8B | $6.8B | $6.8B | $8.5B | $8.6B |
| Net Margin | 14.8% | 17.4% | 16.1% | 18.9% | 20.0% |
| EPS (Diluted) | $177.37 | $208.91 | $207.95 | $261.48 | $263.86 |
| EBITDA | $8.4B | $9.0B | $10.2B | $12.1B | $12.0B |
| Shares Outstanding | 32M | 32M | 32M | 32M | 32M |